The size of the mammography market in Europe was valued at USD 433.4 million in 2019. This value is expected to reach USD 573.73 million by the end of 2024, with a CAGR of 5.77% during the forecast period.
In the review period, Breast cancer is the most prominent disease-causing death among women worldwide. Mammography devices aids in the detention of breast cancer in early stages. The increasing mortality rate has risen the need for diagnosing breast cancer patients leading to increasing demand for mammography devices.
Mammography is a standard diagnostic and screening technique for screening the breast tissues for any malignant tissues. The testing is done through low dose X-rays to get detailed imaging of the inside of the breast. Screening mammography involves random checking among women for breast cancer without any signs of the disease. Whereas, diagnostic mammography is undertaken if there are any symptoms of the disease and can also be used in evaluating the results of the screening mammogram.
The mammography market's driving factors include rising prevalence of cancer, technological innovations in breast imaging, increasing aging population, and rising awareness among individuals propelling early breast screening. However, the market is hampered by the enormous costs associated with the expensive imaging, stringent regulatory bodies, and side effects associated with these devices.
This research report segmented and sub-segmented the Europe Mammography Market into the following categories:
Regional Analysis
The European Mammography market is the second leading region in the global market. Growing incidences of chronic diseases, advancement in technology, and emerging research facilities in this region are majorly driving the market growth.
Among different nations of Europe, Germany is one of the fastest-growing markets due to the gigantic productive economy, adoption of advanced technology, and rising incidences of breast cancer are majorly driving the German mammography market. In 2018, around 72,000 new cases of breast cancer were recorded in which 19,000 women were dead.
However, the United Kingdom's mammography market is estimated to record the highest growth rate during the forecast period. Breast cancer is the fourth most leading cause of cancer deaths in the UK and registered 7% of cancer deaths in 2017. From 2015 to 2017, an average of 31 women was passed away due to breast cancer. This rising prevalence and incidence of breast cancer in the United Kingdom is estimated to offer significant growth to the UK mammography market.
Some of the prominent companies leading the Europe Mammography Market Profiled in the Report are include Fujifilm, GE Healthcare, Hologic, Metaltronica, Philips Healthcare, Planmed, Siemens Healthcare, Sonocine, and Toshiba Medical Systems.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 3D mammograms
5.1.3 Digital System
5.1.4 Analog System
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Technology
5.2.1 Introduction
5.2.2 Analog Mammography
5.2.3 Digital Mammography
5.2.4 Breast Tomosynthesis
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Screening Mammograms
5.3.3 Diagnostic Mammograms
5.3.4 Other Applications
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Tecchnology
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technology
6.1.5.4 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Siemens Healthcare
8.3 Toshiba Medical Systems
8.4 Metaltronica
8.5 Sonocine Inc.
8.6 Fujifilm
8.7 Hologic Inc.
8.8 Philips Healthcare
8.9 Planmed
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
